Combination of pirtobrutinib and lentiviral transduced bispecific anti-CD20/CD 19 (LV20.19) CART-cell therapy to improve outcomes in patients with relapsed/refractory lymphoma Journal of Clinical Oncology 42(suppl 16; abstr 7043). POSTER
Date
02/14/2025
Author List
Furqan, F., K. Palen, B.D. Johnson, T. Kearl, P. Hematti, W. Longo, M. Hamadani, T. Fenske, and N.N. Shah
Author
Walter L. Longo MD Professor in the Medicine department at Medical College of Wisconsin